These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7483456)
1. [Radiomodifiers and the progress of radiation oncology]. Iarmonenko SP Vopr Onkol; 1995; 41(2):93-4. PubMed ID: 7483456 [No Abstract] [Full Text] [Related]
2. Cancer trends: the potential of radiation modifiers. Elkon D Va Med; 1981 Feb; 108(2):120-4. PubMed ID: 7210858 [No Abstract] [Full Text] [Related]
3. Radiobiological modifiers in clinical radiation oncology: current reality and future potential. Allison RR Future Oncol; 2014 Dec; 10(15):2359-79. PubMed ID: 25525845 [TBL] [Abstract][Full Text] [Related]
4. [Radiobiology and the progress of radiation oncology]. Khanson KP; Dar'ialova SA; Konopliannikov AG; Pelevina II; Iarmonenko SP Vopr Onkol; 1995; 41(2):54-61. PubMed ID: 7483437 [No Abstract] [Full Text] [Related]
5. Radiation modifiers: treatment overview and future investigations. Thomas CT; Ammar A; Farrell JJ; Elsaleh H Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560 [TBL] [Abstract][Full Text] [Related]
6. Assessment of chlorpromazine as radiation sensitizer and protector. Huilgol NG; Chatterjee N; Singh BB Indian J Cancer; 1996 Dec; 33(4):195-200. PubMed ID: 9255000 [TBL] [Abstract][Full Text] [Related]
7. Chemical radiation sensitizers and protectors: recent developments. Kim JH; Chu FC Clin Bull; 1981; 11(1):5-11. PubMed ID: 6268335 [No Abstract] [Full Text] [Related]
8. [Recent advances in radiation oncology]. Kouri M; Kajanti M; Blomqvist C; Tenhunen M; Minn H Duodecim; 1996; 112(18):1715-22. PubMed ID: 10596170 [No Abstract] [Full Text] [Related]
12. Carcinogenic, mutagenic, teratogenic workshop. Suit H; Hall E; Frei E Cancer Clin Trials; 1981; 4 Suppl():37-41. PubMed ID: 7307224 [No Abstract] [Full Text] [Related]
13. [Quantitative evaluation of the effectiveness of radiomodifiers in local irradiation of the skin]. Vygodskaia AL; Vinskaia NP; Krimker VM Med Radiol (Mosk); 1982 Mar; 27(3):52-5. PubMed ID: 6281606 [No Abstract] [Full Text] [Related]
14. New designs for radiation oncology research in clinical trials. Rubin P; Keys H; Salazar O Semin Oncol; 1981 Dec; 8(4):453-72. PubMed ID: 7323819 [No Abstract] [Full Text] [Related]
15. [Theoretical bases for using modifying agents in the radiation therapy of malignant neoplasms (the Modifier program)]. Kuzin AM; Tsyb AF; Iarmonenko SP; Pelevina II; Konopliannikov AG Radiobiologiia; 1981; 21(5):744-51. PubMed ID: 7031758 [No Abstract] [Full Text] [Related]
16. New treatment modalities in radiation therapy. Holland J J Intraven Nurs; 2001; 24(2):95-101. PubMed ID: 11836839 [TBL] [Abstract][Full Text] [Related]
17. Altering the response to radiation: sensitizers and protectors. Citrin DE; Mitchell JB Semin Oncol; 2014 Dec; 41(6):848-59. PubMed ID: 25499642 [TBL] [Abstract][Full Text] [Related]
18. Radiation oncology, resident research, and the American Board of Radiology Holman Pathway. Wilson LD; Haffty BG; Harris JR Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):623-5. PubMed ID: 15936535 [No Abstract] [Full Text] [Related]
19. Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors. Advani SJ; Chmura SJ; Weichselbaum RR Semin Oncol; 1997 Dec; 24(6):633-8. PubMed ID: 9422260 [TBL] [Abstract][Full Text] [Related]
20. Chemical modifiers of normal-tissue radiation injury. Phillips TL Front Radiat Ther Oncol; 1989; 23():177-84. PubMed ID: 2697653 [No Abstract] [Full Text] [Related] [Next] [New Search]